Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

M1 Kliniken AG (M12) Price & Analysis

M12 Stock Chart & Stats

€19.56-€0.14(-0.71%)
At close: 4:00 PM EDT
EUR 18EUR 19EUR 20EUR 213 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 19.24 - EUR 19.70
52-Week Range
EUR 13.62 - EUR 21.70
Previous Close
EUR 19.70
Volume
52
Average Volume (3M)
2,698
Market Cap
EUR 344.06M
Enterprise Value
EUR 336.14M
Total Cash (Recent Filing)
EUR 60.50M
Total Debt (Recent Filing)
EUR 5.90M
Price to Earnings (P/E)
17.9
Beta
0.34
Next Earnings
Nov 18, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
6.13%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage reduces financing pressure and preserves flexibility for clinic expansion, investment, or shareholder returns. Growing equity provides an additional buffer against operating volatility, while modest debt limits the drag from interest costs over the next several quarters.

Strong Recent Cash Generation

Strong operating and free cash flow indicate that reported earnings are translating into usable funds. This supports self-funded growth, improves resilience during demand changes, and gives management more capacity to maintain operations without relying heavily on additional borrowing.

Improved Profitability And Sustained Revenue Growth

Multi-year revenue growth combined with a substantial rise in net income suggests improving scale and operating leverage across the business. A larger earnings base can strengthen reinvestment capacity and provide a more durable foundation for future clinic and product activity.

Bears Say

Revenue Growth Is Slowing

The continued deceleration in annual revenue growth indicates that expansion and demand momentum are moderating. If this pattern persists, slower top-line progression could limit operating leverage, reduce the pace of earnings growth, and make future performance more dependent on margin improvement.

Margin Sustainability Remains Uncertain

Historical gross-margin volatility makes it harder to determine whether the stronger profitability achieved through 2024 is durable. Without clear evidence that margins held in 2025, earnings may remain sensitive to treatment mix, pricing, and cost changes over the next several quarters.

Cash Flow Has Been Volatile

The sharp cash-flow trough in 2023 shows that conversion from operations can fluctuate materially between years. Although recent performance is strong, renewed volatility could affect internal funding for expansion, reduce predictability, and complicate capital allocation decisions.

M12 FAQ

What was M1 Kliniken AG’s price range in the past 12 months?
M1 Kliniken AG lowest stock price was €13.62 and its highest was €21.70 in the past 12 months.
What is M1 Kliniken AG’s market cap?
M1 Kliniken AG’s market cap is €344.06M.
When is M1 Kliniken AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were M1 Kliniken AG’s earnings last quarter?
M1 Kliniken AG released its earnings results on Sep 09, 2026. The company reported €0.52 earnings per share for the quarter.
Is M1 Kliniken AG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does M1 Kliniken AG pay dividends?
M1 Kliniken AG pays a Annually dividend of €1.2 which represents an annual dividend yield of 6.13%. See more information on M1 Kliniken AG dividends here
What is M1 Kliniken AG’s EPS estimate?
M1 Kliniken AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does M1 Kliniken AG have?
M1 Kliniken AG has 18,555,115 shares outstanding.
What happened to M1 Kliniken AG’s price movement after its last earnings report?
M1 Kliniken AG reported an EPS of €0.52 in its last earnings report. Following the earnings report the stock price went up 0.494%.
Which hedge fund is a major shareholder of M1 Kliniken AG?
Currently, no hedge funds are holding shares in DE:M12
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology